[1]龙继贤,高文妹.ST段抬高型急性心肌梗死早期脑钠肽水平变化及各个时间点检测对心力衰竭的诊断价值[J].陕西医学杂志,2019,(5):595-598,602.
 LONG Jixian,GAO Wenmei..The change of brain natriuretic peptide(BNP)concentration in the early stage of STsegment elevationacute myocardial infarction and the diagnostic value of BNP at different time points for heart failure at that time[J].,2019,(5):595-598,602.
点击复制

ST段抬高型急性心肌梗死早期脑钠肽水平变化及各个时间点检测对心力衰竭的诊断价值
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2019年5期
页码:
595-598,602
栏目:
临床研究
出版日期:
2019-05-05

文章信息/Info

Title:
The change of brain natriuretic peptide(BNP)concentration in the early stage of STsegment elevationacute myocardial infarction and the diagnostic value of BNP at different time points for heart failure at that time
文章编号:
DOI: 10.3969/j.issn.10007377.2019.05.015
作者:
龙继贤高文妹
上海市徐汇区大华医院急诊医学科(上海200237)
Author(s):
LONG JixianGAO Wenmei.
Emergency Department,Dahua Hospital of Shanghai Xuhui District(Shanghai 200237)
关键词:
脑钠肽ST段抬高型急性心肌梗死心力衰竭相关性诊断对比研究
Keywords:
Key words Brain natriuretic peptide STsegment elevation acute myocardial infarction Heart failure Correlation DiagnoseComparative study
分类号:
R541.4
文献标志码:
A
摘要:
摘 要 目的:研究ST段抬高型急性心肌梗死(STEMI)患者早期脑钠肽(BNP)水平变化情况,分析各个时间点BNP水平对心力衰竭的诊断价值。方法:118例STEMI患者作为研究对象。根据Killip分级分为心力衰竭组(n=42)和非心力衰竭组(n=76)。分析两组患者不同时间点的BNP水平情况和STEMI患者BNP水平的影响因素,分析不同时间点BNP水平与Killip分级的关系。结果:心力衰竭患者在发病6、12、24、48 h时BNP水平分别为(52.96±10.12) pg/ml、(172.43±25.38) pg/ml、(471.24±51.72) pg/ml和(374.69±33.42) pg/ml,均明显高于非心力衰竭患者的(12.58±2.69) pg/ml、(75.82±12.36) pg/ml、(179.27±20.64) pg/ml和(118.42±19.76) pg/ml(均P<0.05)。发病6~24 h,所有患者BNP水平随着时间的延长而增高,发病24~48 h,所有患者BNP水平随着时间的延长而降低(均P<0.05)。等级Logistic回归分析显示,Killip分级较低、前壁心肌梗死、男性和发病至球囊扩张时间较短是STEMI患者BNP水平较低的影响因素(均P<0.05)。BNP浓度在发病6、12 h时与Killip分级呈较弱正相关,发病24、48 h时,BNP浓度与Killip分级呈较强正相关(均P<0.05)。结论:BNP水平随着STEMI患者发病时间的延长而升高,约24 h达峰值。BNP在STEMI患者发病≤12 h及>24 h对心力衰竭的诊断价值较低,STEMI患者发病12~24 h BNP对心力衰竭的诊断价值较高。
Abstract:
Abstract Objective:To study the changes of early brain natriuretic peptide(BNP) concentration in STsegment elevation acute myocardial infarction(STEMI) patients, and to analyze the diagnostic value of BNP concentration at each time point for heart failure at that time. Methods:118 cases STEMI admitted to our hospital from August 2015 to August 2017 were included in the study.They were divided into heart failure group(n=42) and non heart failure group(n=76).The levels of BNP at different time points in 2 groups were analyzed, and the influencing factors of BNP level in STEMI patients were analyzed, and the relationship between BNP level and Killip grading at different time points was analyzed. Results: The levels of BNP in STEMI patients with heart failure were (52.96±10.12) pg/ml, (172.43±25.38) pg/ml, (471.24±51.72) pg/ml and (374.69±33.42) pg/ml at the onset of 6,12,24 and 48 h, which were significantly higher than those of non heart failure STEMI patients (12.58±2.69)pg/ml, (75.82±12.36)pg/ml, (179.27±20.64)pg/ml and (118.42±19.76) pg/ml(all P<0.05). The levels of BNP had increased with time in all patients at onset of 6~24 h, and the BNP levels had decreased at onset of 24~48 h(all P<0.05). Logistic regression analysis showed that lower Killip grade, anterior wall myocardial infarction, male and shorter time to onset to balloon expansion are factors influencing lower BNP levels in STEMI patients(all P<0.05). BNP level was positively correlated with Killip grade at onset of 6~12 h, and BNP concentration was positively correlated with Killip grade at onset of 24~48 h(all P<0.05).Conclusion:The level of BNP increasing with the prolongation of the onset time of STEMI, and reaches the highest value at onset of 24 h. The value of BNP is lower in the〖LM〗 diagnosis of STEMI combined with heart failure within 12 h of STEMI. The diagnostic value of onset time of 12~24 h and >24 h BNP in STEMI combined with heart failure is significantly higher than that of onset time of 24 h.

参考文献/References:

[1] Stankovic S, Obradovic S, Dzudovic B, et al.Lower plasma protein C activity is associated with early myocardial necrosis and noreflow phenomenon in patients with ST elevation myocardial infarction[J].Acta Cardiol,2018,11(9):1-9. [2] 陈 峰,庞继恩,孙 强,等.急性心肌梗死患者冠状动脉循环血清高肌钙蛋白T含量变化及意义[J].中国心血管病研究,2012,10(5):355-357. [3] Antoni ML,Hoogslag GE,Boden H,et al.Cardiovascular mortality and heart failure risk score for patients after STsegment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (Data from the Leiden MISSION! Infarct Registry)[J].Am J Cardiol,2012,109(2):187-194. [4] 边召允.血清N端脑钠肽前体,心肌肌钙蛋白T及超敏C反应蛋白水平变化对心力衰竭患者诊断的临床意义[J].医学检验与临床,2015,26(5):69-70,72. [5] AbdelDayem K, Eweda II, ElSherbiny A,et al.Cutoff value of admission nterminal probrain natriuretic peptide which predicts poor myocardial perfusion after primary percutaneous coronary intervention for stsegmentelevation myocardial infarction[J].Acta Cardiol Sin,2016 ,32(6):649-655. [6] 蔡天志,张科林,张安吉,等.急性心肌梗死后急性心力衰竭患者血中卵泡抑素样蛋白1的变化及临床意义[J].山西医药杂志,2015,44(9):971-973. [7] Ponikowski P, Voors AA, Anker SD, et al.2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure[J].Rev Esp Cardiol (Engl Ed),2016,69(12):1167. [8] Okabe T,Yakushiji T,Shimazu S,et al.Serum zinc concentration in patients with acute myocardial infarction in percutaneous coronary intervention era[J].PLoS One,2018,13(8):e0203074. [9] 吴文凤.AMI患者治疗前后血浆BNP、ANP、CKMB的变化及其临床意义[J].西南国防医药,2016,26(1):1720. [10] Kim MC, Jeong MH, Sim DS, et al.Optimal timing of percutaneous coronary intervention in patients with nonstsegment elevation myocardial infarction complicated by acute decompensated heart failure (from the korea acute myocardial infarction registrynational institutes of health\[KAMIRNIH\])[J].Am J Cardiol,2018,121(11):12851292. [11] 曹钏宏,方雪红,徐 博.心电图结合脑钠肽检测对老年急性左心衰患者预后临床观察[J].陕西医学杂志,2015,46(7):886887,888. [12] 齐延伟,吴忠荣,马振刚,等.参麦配合瑞通立治疗急性心肌梗塞ST 段抬高型及对心室功能和血浆脑钠肽水平的影响[J].陕西中医,2015,34(5):562564. [13] 陈 佳.sST2和NTproBNP对AMI合并心力衰竭患者预后、诊断价值评估[J].医学综述,2015,21(23):43904392. [14] Yancy CW,Jessup M,Bozkurt B,et al.2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines[J].Circulation,2013,128(16):18101852. [15] 吴秀娟,王忠民,刘煜昊,等.血清生物标记物对急性心肌梗死患者院内心功能衰竭的预测价值[J].岭南心血管病杂志,2017,23(5):511515,520. [16] Kristensen SL,Preiss D,Jhund PS,et al.Risk related to prediabetes mellitus and diabetes mellitus in heart failure with reduced ejection fraction: insights from prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial[J].Circ Heart Fail,2016,9(1):e002560. [17] 邓诗武.GDF15、cTnⅠ、BNP在急性心肌梗死病人中的关系及对其近期预后的预测价值[J].中西医结合心脑血管病杂志,2017,15(18):22942296. [18] 赵旭林,张 琳,侯慧云.脑钠肽、高敏C反应蛋白、血尿酸与老年慢性心力衰竭相关性研究[J].陕西医学杂志,2013,42(8):10491050. [19] 中国医学前沿杂志编辑部.《急性ST段抬高型心肌梗死溶栓治疗的合理用药指南》第2版在京发布[J].中国医学前沿杂志:电子版,2018,10(12):95. [20] 张晓华.60例非ST段抬高型急性心肌梗死患者临床特征及预后分析[J].数理医药学杂志,2019,32(1):911. [21] 魏 来.急性心肌梗死患者PCI术后主要不良心血管事件发生的影响因素[J].心血管康复医学杂志,2018,27(6):633637. [22] 贾圣英,谢莲娜,王凯君,等.不同年龄段急性冠状动脉综合征患者临床及预后分析[J].心脑血管病防治,2018,18(6):448451. [23] 姚自鹏,王 琳,宗 政,等.缺血后适应在急性心肌梗死介入治疗中的研究进展[J].中国老年学杂志,2018,38(21):53685371.

相似文献/References:

[1]陈伟国,张晓萌,常 盼,等.阿托伐他汀对2型糖尿病心肌病患者心功能、脑钠肽、超敏C反应蛋白影响临床研究*[J].陕西医学杂志,2019,(1):10.
 CHEN Weiguo,ZHANG Xiaomeng,CHANG Pan,et al.Clinical research of atorvastatinon on cardiacfunction,brain natriuretic peptide and hypersensitive Creactive protein in patients with diabetic cardiomyopathies[J].,2019,(5):10.
[2]路 飞,王妍妍△,胡 涛.不同起源频发室性早搏患者射频消融术后左心房功能及结构变化临床研究*[J].陕西医学杂志,2019,(12):1642.
 LU Fei,WANG Yanyan,HU Tao..Clinical study on left atrial function and structure changes in patients with frequent premature ventricular contractions of different origins after RFCA[J].,2019,(5):1642.
[3]耿 鹃,周 耀,刘旭辉.微小RNA-492、红细胞微粒水平与ST段抬高型急性心肌梗死患者冠状动脉病变严重程度关系研究[J].陕西医学杂志,2024,(9):1249.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.021]
 GENG Juan,ZHOU Yao,LIU Xuhui.Relationship between level of miR-492,erythrocyte microparticles and severity of coronary artery lesions in STEMI patients[J].,2024,(5):1249.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.021]

更新日期/Last Update: 2019-05-07